Ulys, L.L.C.

SEC CIK: 0001340098
Latest filing: May 14, 2021

SEC filings (opens in a new tab)

LXRX holding history

Lexicon Pharmaceuticals, Inc. in every 13F filed by Ulys, L.L.C., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LXRX overview All 13F holders of LXRX Full Q1 2021 holdings

Shares (Q1 2021): 4,321,214
Value: $25.4M
% of portfolio: 100.0%
Quarters held: 1; Since Q1 2021

Holdings of LXRX by Ulys, L.L.C., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2021	4,321,214	$25.4M	100.0%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.